Douglas M. Coldwell

TL;DR: Optimal periprocedural care, discharge planning, and follow-up care are essential to assess treatment response and ensure that short-term side effects of radioembolization are adequately managed.

TL;DR: By using stringent selection criteria and conservative models for calculating radiation dosage, radioembolization can be performed safely even in cirrhotic patients, without postembolized syndrome or radiation-induced liver disease, and even with multiple treatments to whole or part of the liver.

TL;DR: This review provides recommendations to multidisciplinary teams on the optimal medical processes in order to ensure the safe delivery of selective internal radiation therapy and the best available published evidence and expert opinion.

TL;DR: Radioembolization appears to have a favorable risk/benefit profile, even among mCRC patients who had received ≥3 prior lines of chemotherapy, and significantly prolonged in patients with ECOG 0 vs. ≥1.

TL;DR: Treatment with the biliary intraluminal irradiation stent in patients with biliary obstruction caused by adenocarcinomas appears safe and technically feasible, has benefits in relieving jaundice, and seems to extend survival when compared to a conventional biliary stent.